Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer
Solomon, Benjamin J, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Tang, Yiyun, Wilner, Keith D, Blackhall, Fiona, Mok, Tony S
Published in Journal of clinical oncology (01.08.2018)
Published in Journal of clinical oncology (01.08.2018)
Get full text
Journal Article
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Solomon, Benjamin J, Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Tursi, Jennifer, Blackhall, Fiona
Published in The New England journal of medicine (04.12.2014)
Published in The New England journal of medicine (04.12.2014)
Get full text
Journal Article
Web Resource
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Drilon, Alexander, Clark, Jeffrey W., Weiss, Jared, Ou, Sai-Hong Ignatius, Camidge, D. Ross, Solomon, Benjamin J., Otterson, Gregory A., Villaruz, Liza C., Riely, Gregory J., Heist, Rebecca S., Awad, Mark M., Shapiro, Geoffrey I., Satouchi, Miyako, Hida, Toyoaki, Hayashi, Hidetoshi, Murphy, Danielle A., Wang, Sherry C., Li, Sherry, Usari, Tiziana, Wilner, Keith D., Paik, Paul K.
Published in Nature medicine (01.01.2020)
Published in Nature medicine (01.01.2020)
Get full text
Journal Article
CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib
Costa, Daniel B, Kobayashi, Susumu, Pandya, Shuchi S, Yeo, Wee-Lee, Shen, Zhongzhou, Tan, Weiwei, Wilner, Keith D
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer
Wu, Yi-Long, Yang, James Chih-Hsin, Kim, Dong-Wan, Lu, Shun, Zhou, Jianying, Seto, Takashi, Yang, Jin-Ji, Yamamoto, Noboru, Ahn, Myung-Ju, Takahashi, Toshiaki, Yamanaka, Takeharu, Kemner, Allison, Roychowdhury, Debasish, Paolini, Jolanda, Usari, Tiziana, Wilner, Keith D, Goto, Koichi
Published in Journal of clinical oncology (10.05.2018)
Published in Journal of clinical oncology (10.05.2018)
Get full text
Journal Article
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
BERGETHON, Kristin, SHAW, Alice T, MARK, Eugene J, BATTEN, Julie M, HAIQUAN CHEN, WILNER, Keith D, KWAK, Eunice L, CLARK, Jeffrey W, CARBONE, David P, HONGBIN JI, ENGELMAN, Jeffrey A, MINO-KENUDSON, Mari, IGNATIUS OU, Sai-Hong, PAO, William, IAFRATE, A. John, KATAYAMA, Ryohei, LOVLY, Christine M, MCDONALD, Nerina T, MASSION, Pierre P, SIWAK-TAPP, Christina, GONZALEZ, Adriana, RONG FANG
Published in Journal of clinical oncology (10.03.2012)
Published in Journal of clinical oncology (10.03.2012)
Get full text
Journal Article
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Costa, Daniel B, Shaw, Alice T, Ou, Sai-Hong I, Solomon, Benjamin J, Riely, Gregory J, Ahn, Myung-Ju, Zhou, Caicun, Shreeve, S Martin, Selaru, Paulina, Polli, Anna, Schnell, Patrick, Wilner, Keith D, Wiltshire, Robin, Camidge, D Ross, Crinò, Lucio
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
Solomon, Benjamin J, Cappuzzo, Federico, Felip, Enriqueta, Blackhall, Fiona H, Costa, Daniel B, Kim, Dong-Wan, Nakagawa, Kazuhiko, Wu, Yi-Long, Mekhail, Tarek, Paolini, Jolanda, Tursi, Jennifer, Usari, Tiziana, Wilner, Keith D, Selaru, Paulina, Mok, Tony S K
Published in Journal of clinical oncology (20.08.2016)
Published in Journal of clinical oncology (20.08.2016)
Get full text
Journal Article
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
LENNERZ, Jochen K, KWAK, Eunice L, SALGIA, Ravi, BANG, Yung-Jue, CLARK, Jeffrey W, SOLOMON, Benjamin J, JOHN IAFRATE, A, ACKERMAN, Allison, MICHAEL, Michael, FOX, Stephen B, BERGETHON, Kristin, LAUWERS, Gregory Y, CHRISTENSEN, James G, WILNER, Keith D, HABER, Daniel A
Published in Journal of clinical oncology (20.12.2011)
Published in Journal of clinical oncology (20.12.2011)
Get full text
Journal Article
Crizotinib in Patients With MET-Amplified NSCLC
Camidge, D. Ross, Otterson, Gregory A., Clark, Jeffrey W., Ignatius Ou, Sai-Hong, Weiss, Jared, Ades, Steven, Shapiro, Geoffrey I., Socinski, Mark A., Murphy, Danielle A., Conte, Umberto, Tang, Yiyun, Wang, Sherry C., Wilner, Keith D., Villaruz, Liza C.
Published in Journal of thoracic oncology (01.06.2021)
Published in Journal of thoracic oncology (01.06.2021)
Get full text
Journal Article
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Shaw, Alice T, Kim, Dong-Wan, Nakagawa, Kazuhiko, Seto, Takashi, Crinó, Lucio, Ahn, Myung-Ju, De Pas, Tommaso, Besse, Benjamin, Solomon, Benjamin J, Blackhall, Fiona, Wu, Yi-Long, Thomas, Michael, O'Byrne, Kenneth J, Moro-Sibilot, Denis, Camidge, D. Ross, Mok, Tony, Hirsh, Vera, Riely, Gregory J, Iyer, Shrividya, Tassell, Vanessa, Polli, Anna, Wilner, Keith D, Jänne, Pasi A
Published in The New England journal of medicine (20.06.2013)
Published in The New England journal of medicine (20.06.2013)
Get full text
Journal Article
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations
Mok, Tony S., Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Chawla, Alka, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Noonan, Kay, Tang, Yiyun, Pastel, Malaika, Wilner, Keith D., Wu, Yi-Long
Published in Drugs (New York, N.Y.) (01.02.2021)
Published in Drugs (New York, N.Y.) (01.02.2021)
Get full text
Journal Article
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
Wu, Yi-Long, Lu, Shun, Lu, You, Zhou, Jianying, Shi, Yuan-kai, Sriuranpong, Virote, Ho, James C.M., Ong, Choo Khoon, Tsai, Chun-Ming, Chung, Chin-Hee, Wilner, Keith D., Tang, Yiyun, Masters, Elizabeth T., Selaru, Paulina, Mok, Tony S.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, Alice T, Ou, Sai-Hong I, Bang, Yung-Jue, Camidge, D. Ross, Solomon, Benjamin J, Salgia, Ravi, Riely, Gregory J, Varella-Garcia, Marileila, Shapiro, Geoffrey I, Costa, Daniel B, Doebele, Robert C, Le, Long Phi, Zheng, Zongli, Tan, Weiwei, Stephenson, Patricia, Shreeve, S. Martin, Tye, Lesley M, Christensen, James G, Wilner, Keith D, Clark, Jeffrey W, Iafrate, A. John
Published in The New England journal of medicine (20.11.2014)
Published in The New England journal of medicine (20.11.2014)
Get full text
Journal Article
Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
FLAHERTY, Keith T, LORUSSO, Patricia M, DEMICHELE, Angela, ABRAMSON, Vandana G, COURTNEY, Rachel, RANDOLPH, Sophia S, SHAIK, M. Naveed, WILNER, Keith D, O'DWYER, Peter J, SCHWARTZ, Gary K
Published in Clinical cancer research (15.01.2012)
Published in Clinical cancer research (15.01.2012)
Get full text
Journal Article
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Mossé, Yael P, Dr, Lim, Megan S, MD, Voss, Stephan D, MD, Wilner, Keith, PhD, Ruffner, Katherine, MD, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Prof, Maris, John M, Prof, Weigel, Brenda J, MD, Ingle, Ashish M, MS, Ahern, Charlotte, PhD, Adamson, Peter C, Prof, Blaney, Susan M, Prof
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study
Camidge, D Ross, Dr, Bang, Yung-Jue, Prof, Kwak, Eunice L, MD, Iafrate, A John, MD, Varella-Garcia, Marileila, Prof, Fox, Stephen B, Prof, Riely, Gregory J, MD, Solomon, Benjamin, MBBS, Ou, Sai-Hong I, MD, Kim, Dong-Wan, Prof, Salgia, Ravi, Prof, Fidias, Panagiotis, MD, Engelman, Jeffrey A, MD, Gandhi, Leena, MD, Jänne, Pasi A, MD, Costa, Daniel B, MD, Shapiro, Geoffrey I, MD, LoRusso, Patricia, DO, Ruffner, Katherine, MD, Stephenson, Patricia, ScD, Tang, Yiyun, PhD, Wilner, Keith, PhD, Clark, Jeffrey W, MD, Shaw, Alice T, MD
Published in The lancet oncology (01.10.2012)
Published in The lancet oncology (01.10.2012)
Get full text
Journal Article
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
Butrynski, James E, D'Adamo, David R, Hornick, Jason L, Dal Cin, Paola, Antonescu, Cristina R, Jhanwar, Suresh C, Ladanyi, Marc, Capelletti, Marzia, Rodig, Scott J, Ramaiya, Nikhil, Kwak, Eunice L, Clark, Jeffrey W, Wilner, Keith D, Christensen, James G, Jänne, Pasi A, Maki, Robert G, Demetri, George D, Shapiro, Geoffrey I
Published in The New England journal of medicine (28.10.2010)
Published in The New England journal of medicine (28.10.2010)
Get full text
Journal Article
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
Magnuson, Allison, Bruinooge, Suanna S, Singh, Harpreet, Wilner, Keith D, Jalal, Shadia, Lichtman, Stuart M, Kluetz, Paul G, Lyman, Gary H, Klepin, Heidi D, Fleury, Mark E, Hirsch, Brad, Melemed, Allen, Arnaldez, Fernanda I, Basu Roy, Upal, Schenkel, Caroline, Sherwood, Shimere, Garrett-Mayer, Elizabeth
Published in Clinical cancer research (01.05.2021)
Published in Clinical cancer research (01.05.2021)
Get full text
Journal Article
Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1
Awad, Mark M, Katayama, Ryohei, McTigue, Michele, Liu, Wei, Deng, Ya-Li, Brooun, Alexei, Friboulet, Luc, Huang, Donghui, Falk, Matthew D, Timofeevski, Sergei, Wilner, Keith D, Lockerman, Elizabeth L, Khan, Tahsin M, Mahmood, Sidra, Gainor, Justin F, Digumarthy, Subba R, Stone, James R, Mino-Kenudson, Mari, Christensen, James G, Iafrate, A. John, Engelman, Jeffrey A, Shaw, Alice T
Published in The New England journal of medicine (20.06.2013)
Published in The New England journal of medicine (20.06.2013)
Get full text
Journal Article